Search - tctmd.com

Displaying 261 - 280 of 457

Sort: Relevancy | Date

News Conference News EuroPCR 2016

Valvular Interventions for the Asymptomatic and Low Risk: Coming Soon to a Cath Lab Near You?

Yael L. Maxwell

May 20, 2016

News Conference News EuroPCR 2016

Planned MitraClip Implantation Safe, Feasible After TAVR, Small Series Suggests

Yael L. Maxwell

May 20, 2016

Presentation EuroPCR 2016

LAA Occlusion vs Standard Care In Patients With Atrial Fibrillation And Intracerebral Hemorrhage

Presenter: Jens Erik Nielsen-Kudsk

May 20, 2016

News Conference News EuroPCR 2016

Innovative Initiatives in Radiation Safety Lower Patient, Operator Dose in the Cath Lab

Yael L. Maxwell

May 20, 2016

News Conference News EuroPCR 2016

Embolic Protection in TAVR: If, When, What, and How Debated as Trials Wrap Up

Shelley Wood

May 20, 2016

Presentation EuroPCR 2016

Early Percutaneous Intervention for Valvular Disease …An Opportunity for Improving Patient’s Outcome

Presenter: Patrick Serruys

May 20, 2016

News Conference News EuroPCR 2016

Early Data Hint at Good Results With Angiography-Derived FFR

Caitlin E. Cox

May 20, 2016

Presentation EuroPCR 2016

A Patient Level Pooled Analysis of NeuroProtection with the TriGuard Embolic DEFLECTion Device Compared to Unprotected Transcatheter Aortic Valve Replacement

Presenter: Alexandra Lansky

May 20, 2016

News Conference News EuroPCR 2016

Transradial PCI Shows Consistent Benefit in All ACS Patients: MATRIX Access

Michael O'Riordan

May 19, 2016

Presentation EuroPCR 2016

Sealing Moderate Coronary Saphenous Vein Graft Lesions with Drug-Eluting Stents as a New Approach to Reducing Cardiac Events The VELETI II Randomized Trial

Presenter: Josep Rod?s-Cabau

May 19, 2016

News Conference News EuroPCR 2016

Registry Data Help Shore Up the Case for Functional Assessment in ACS, Multivessel Disease

Caitlin E. Cox

May 19, 2016

News Conference News EuroPCR 2016

No Safety Net: TAVR Can Be Done at Centers Without Surgical Backup, German Study Suggests

Michael O'Riordan

May 19, 2016

Presentation EuroPCR 2016

Impact of Coronary Artery Disease on Clinical Outcomes Among Patients Undergoing Transcatheter Aortic Valve Implantation: An Age- and Sex-Matched Cohort Study

Presenter: Anna Franzone

May 19, 2016

Presentation EuroPCR 2016

First Look at Long-term Durability of Transcatheter Heart Valves: Assessment of Valve Function up To 10-years After Implantation

Presenter: Danny Dvir

May 19, 2016

News Conference News EuroPCR 2016

Closer Look at Effects of CAD on TAVR Outcomes Unearths Grim Prognosis

Yael L. Maxwell

May 19, 2016

Presentation EuroPCR 2016

Biolimus-A9 polymer-free coated stent in high bleeding risk patients with acute coronary syndrome: a LEADERS FREE ACS substudy

Presenter: Christoph Naber

May 19, 2016

Presentation EuroPCR 2016

Transcatheter Mitral Valve Replacement in Native Mitral Valve Disease with Severe Mitral Annular Calcification

Presenter: Mayra Guerrero

May 18, 2016

News Conference News EuroPCR 2016

Stent ‘Sealing’ of Nonobstructive Saphenous Vein Graft Plaques Fails to Prevent CV Events

Shelley Wood

May 18, 2016

News Conference News EuroPCR 2016

Of Hands and Hearts: Upper-Extremity Dysfunction Common Early After Transradial PCI

Michael O'Riordan

May 18, 2016

News Conference News EuroPCR 2016

LAA Closure May Provide Solution for Stroke Prevention in Patients With Prior Intracerebral Hemorrhage

Yael L. Maxwell

May 18, 2016

Advertisement

Valvular Interventions for the Asymptomatic and Low Risk: Coming Soon to a Cath Lab Near You?

Planned MitraClip Implantation Safe, Feasible After TAVR, Small Series Suggests

LAA Occlusion vs Standard Care In Patients With Atrial Fibrillation And Intracerebral Hemorrhage

Innovative Initiatives in Radiation Safety Lower Patient, Operator Dose in the Cath Lab

Embolic Protection in TAVR: If, When, What, and How Debated as Trials Wrap Up

Early Percutaneous Intervention for Valvular Disease …An Opportunity for Improving Patient’s Outcome

Early Data Hint at Good Results With Angiography-Derived FFR

A Patient Level Pooled Analysis of NeuroProtection with the TriGuard Embolic DEFLECTion Device Compared to Unprotected Transcatheter Aortic Valve Replacement

Transradial PCI Shows Consistent Benefit in All ACS Patients: MATRIX Access

Sealing Moderate Coronary Saphenous Vein Graft Lesions with Drug-Eluting Stents as a New Approach to Reducing Cardiac Events The VELETI II Randomized Trial

Registry Data Help Shore Up the Case for Functional Assessment in ACS, Multivessel Disease

No Safety Net: TAVR Can Be Done at Centers Without Surgical Backup, German Study Suggests

Impact of Coronary Artery Disease on Clinical Outcomes Among Patients Undergoing Transcatheter Aortic Valve Implantation: An Age- and Sex-Matched Cohort Study

First Look at Long-term Durability of Transcatheter Heart Valves: Assessment of Valve Function up To 10-years After Implantation

Closer Look at Effects of CAD on TAVR Outcomes Unearths Grim Prognosis

Biolimus-A9 polymer-free coated stent in high bleeding risk patients with acute coronary syndrome: a LEADERS FREE ACS substudy

Transcatheter Mitral Valve Replacement in Native Mitral Valve Disease with Severe Mitral Annular Calcification

Stent ‘Sealing’ of Nonobstructive Saphenous Vein Graft Plaques Fails to Prevent CV Events

Of Hands and Hearts: Upper-Extremity Dysfunction Common Early After Transradial PCI

LAA Closure May Provide Solution for Stroke Prevention in Patients With Prior Intracerebral Hemorrhage

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content